Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 2Genitourinary 1Gastrointestinal 1

Conditions

Motor Activity 14Breast Neoplasms 11Polycystic Ovary Syndrome 8Obesity 8Colorectal Neoplasms 8Weight Loss 6Neoplasms 6Prostatic Neoplasms 5Colonic Neoplasms 5Endometrial Neoplasms 4Multiple Endocrine Neoplasia Type 1 3Recurrence 2Pancreatic Neoplasms 2Overweight 2Ovarian Neoplasms 2Malnutrition 2Lymphoma, Follicular 2Lymphoma 2Lung Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Body Weight Changes 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Smoking 1Sexual Dysfunction, Physiological 1

Interventions

Carboplatin 345Cisplatin 240Paclitaxel 208Radiotherapy 206Pemetrexed 190Docetaxel 170Gemcitabine 158pembrolizumab 146Erlotinib Hydrochloride 111Magnetic Resonance Spectroscopy 101Etoposide 98Bevacizumab 96Specimen Handling 84Nivolumab 77durvalumab 73Radiosurgery 73Blood Specimen Collection 65Drug Therapy 61osimertinib 56Vinorelbine 54Gefitinib 50Surveys and Questionnaires 48atezolizumab 44Biopsy 43Irinotecan 42Radiation 41Topotecan 39Standard of Care 38Cyclophosphamide 38Surgical Procedures, Operative 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lung Neoplasms × Diet × Clear all
NCT03785808 2019-08-12

RIGHT

Fred Hutchinson Cancer Center

Phase NA Terminated
3 enrolled
Thoracic

Lung Neoplasms

NCT03410641 2018-01-25

Long-term Cancer Risk in the Randomised Oslo Diet and Antismoking Study

Oslo University Hospital

Completed
1,216 enrolled
GastrointestinalGenitourinaryThoracic

Gastrointestinal Neoplasms, Lung Neoplasms, Neoplasms, Prostatic Neoplasms, Urologic Neoplasms, Weight Loss, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡